As the COVID-19 pandemic evolves, Europe's strategy is to have a broad range of adapted vaccines that target different SARS-CoV-2 variants 'so Member States have a plurality of options to meet their needs.'
In support of that strategy, the European Medicines Agency (EMA) recently announced its committee recommended authorizing enhanced vaccines adapted to provide broader protection against COVID-19.
These adapted vaccines can broaden protection against different variants and are expected to help maintain optimal protection against COVID-19 as the virus evolves.
Europeans Gain Access to COVID-19 Vaccine Boosters
Daily Step Counts Still Down Versus Prepandemic Levels
Global variation seen in recovery, with Europe and North America showing biggest recovery
CDC Expert Panel OKs Omicron-Specific Boosters From Pfizer, Moderna
Hundreds of thousands of updated vaccine doses already being delivered around the country on Thursday
59.5 Percent of Adult ED Visits Are for Patients With Chronic Conditions
Hypertension was the most frequently observed chronic condition; hypertension and diabetes was most frequent pair
U.S. Safety-Net Providers Report Moral Distress in Early Pandemic
Moral distress emerged from being unable to provide optimal care, seeing pandemic’s effects on patients, coworkers
Risks for Neurologic, Psychiatric Sequelae Persist After COVID-19
Adults have increased risks for cognitive deficit, dementia, psychotic disorders, epilepsy or seizures at two-year follow-up
COVID-19 Vaccination in Pregnancy Not Tied to Adverse Birth Outcomes
No increased risk seen for overall preterm birth, spontaneous preterm birth, very preterm birth, SGA, or stillbirth